JAKARTA - Spokesperson of the Indonesian Doctors Association (PB IDI) Iris Rengganis said the Chinese-made vaccine is still worth using, because the efficacy of Chinese-made vaccines such as Sinovac, is still above the threshold set by the World Health Organization (WHO).
"Anyway, WHO announced an efficacy of at least 50 percent. So anything above 50 percent is worth it. The important thing is the vaccines are safe", said Chairman of the Vaccination Implementation Advocacy Team, as well as Spokesperson of PB IDI Iris Rengganis in a press statement, received, in Jakarta, Wednesday, April 14.
According to her, trials and clinical trials of the Sinovac vaccine have been conducted.
She said that in Brazil the test results showed a figure of 50.4 or 50.3 percent for Sinovac.
"Because we need it in the pandemic, so we don't really look at brands anymore", she said.
Most importantly, she said, the vaccine is available and safe. The question of effectiveness does not need to be a problem until it is addressed.
"The effectiveness issues will show as it goes. If necessary, repeat it later, so there's no need to make a fuss. The important thing is that its effectiveness has passed the test from WHO. All of our studies have looked at the effectiveness of these vaccines", she said.
The efficacy of the vaccine had no impact on health. Then, according to her, the vaccine will not poison the recipient, so the vaccine remains safe to use.
He said that the efficacy of the COVID-19 vaccine cannot be compared because the efficacy of each country varies.
"We will see as time goes on the effectiveness of the vaccine that we will see later," he said.
Furthermore, he said, the plan to bring Moderna dan Pfizer vaccines to meet the needs in the country.
According to him, about 70 percent of Indonesians are targeted to receive COVID-19 vaccination. Therefore, the vaccine needed is certainly more.
"So, we need more vaccines, we want from other countries, to meet the needs, so that herd immunity is achieved", said Iris.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
